To further ascertain a role for STEAP4 in diabetes-mediated retinal oxidative stress, non-diabetic (ND) and diabetic (DB) C57BL/6 mice received one intravitreal injection of 5 μg of anti-STEAP4 1-week after diabetes was confirmed. The gene discussed is STEAP4; the disease is diabetes mellitus.